Gilead Sciences Names Daniel ODay Chairman and Chief Executive Officer | GILD Message Board Posts

Gilead Sciences, Inc.

  GILD website

GILD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  11833 of 11893  at  12/10/2018 9:59:54 AM  by

August28


Re: Gilead Sciences Names Daniel ODay Chairman and Chief Executive Officer

 I'm glad to see the CEO and Chairman position resolved with the hire of O'Day, who should bring a wealth of experience and leadership from his days at Roche. I've seen it said that he is not an scientist or clinician, as were Martin and Milligan, but rather holds an MBA.  I see this as a plus, rather than a negative.  GILD needs someone who is able to aggressively seek out business opportunities in the biotech area.  Now perhaps the company can put its cash to work in the next M&A in 2019.  That and the pipeline hopefully coming to fruition soon should return GILD to being a growth company in the near future.  Not ready to jump in for more though until I see the numbers and guidance in the next earnings report.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 243
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
11836 Re: Gilead Sciences Names Daniel ODay Chairman and Chief Executive Officer mr.phil2u 1 12/11/2018 8:37:57 AM


About Us  �  Contact Us  �  Follow Us on Twitter  �  Members Directory  �  Help Center  �  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
� 2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...